Skip to main content

Reporter

Clinical score can guide PRRT therapy decisions for neuroendocrine tumors

Jan. 19, 2022—A clinical score system developed by researchers at Vanderbilt-Ingram Cancer Center (VICC) has been validated that can guide peptide receptor radionuclide therapy treatment decisions.

Read more


Ensuring the “best possible” medication history

Jan. 18, 2022—About 80% of hospital admission electronic records were missing a drug prescribed to an older adult, Vanderbilt researchers found, highlighting the need for a multipronged approach to address medication discrepancies and support safe prescribing practices.

Read more


Inaugural members of the Vanderbilt Academy for Excellence in Clinical Medicine announced

Jan. 17, 2022—The inaugural members of the Vanderbilt Academy for Excellence in Clinical Medicine (AECM) have been chosen.

Read more


H. pylori, lipid loss and stomach cancer

Jan. 17, 2022—H. pylori infection — a strong risk factor for stomach cancer — changes the composition of stomach lipids, which could offer new biomarkers for detecting premalignant changes, Vanderbilt researchers discovered.

Read more


Vanderbilt biostatisticians launch Cancer-Immu data portal for predicting response to immune checkpoint blockade immunotherapy

Jan. 14, 2022—A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors.

Read more


The role of integrins in kidney “integrity”

Jan. 13, 2022—Receptors called integrins play a critical role in maintaining the structure of the kidney, Vanderbilt researchers have discovered.

Read more


NIH grant to address chronic diseases that affect populations with health disparities

Jan. 13, 2022—Vanderbilt University Medical Center, Meharry Medical College and the University of Miami Miller School of Medicine have received a major grant from the National Institutes of Health to jointly develop the Southeast Collaborative for Innovative and Equitable Solutions to Chronic Disease Disparities.

Read more


Salmonella overcomes host resistance

Jan. 13, 2022—The invading pathogen Salmonella, a common cause of food poisoning, can change its metabolism to overcome host resistance to its colonization.

Read more


Bariatric surgery gave LVAD patient second chance at life

Jan. 13, 2022—Veronica Llamas-Barajas is the first LVAD patient at Vanderbilt to undergo bariatric surgery.

Read more


Eve of Janus event benefits Children’s Hospital

Jan. 13, 2022—The Eve of Janus, the longest-running fundraising event for Monroe Carell Jr. Children’s Hospital at Vanderbilt, recently celebrated its 50-year anniversary with a $1 million milestone gift to the hospital’s Tri Delta Pediatric Hematology/Oncology Clinic.

Read more


Study seeks to refine head and neck cancer treatment options

Jan. 13, 2022—  by Bill Snyder Researchers at Case Western Reserve University and Vanderbilt University Medical Center are pioneering the use of computer-aided image analysis to improve the prognostication and treatment of head and neck cancer. Each year in the United States, approximately 16,000 patients are diagnosed with a form of head-and-neck cancer called oropharyngeal squamous cell...

Read more


Treatment sharpens sense of smell for ‘professional nose’

Jan. 13, 2022—Surgery at Vanderbilt helped 25-year-old Meredith Watson pursue her dream of becoming a professional nose — someone specially trained in combining ingredients to create fragrances.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more